Irene Velasco

ORCID: 0000-0001-5497-5813 · 29 papers in corpus · active 2000-2025

Study types

  • article 19
  • preprint 5
  • other 3
  • case-report 1
  • rct 1

Condition tags

  • endometriosis 27
  • mesh:D004715 14
  • infertility 4
  • endometrioma 1
  • die_deep_infiltrating 1
  • mesh:D004412 1
  • mesh:D017699 1
  • mesh:D004716 1
article 2025
The Science of the total environment ·doi:10.1016/j.scitotenv.2025.180270

Endometriosis disease affects up to 10 % of menstruating people worldwide and can lead to infertility. Environmental pollutants are risk factors influencing the probability of developing endometriosis. We aimed to explore the differences in…

article 2024
·doi:10.1016/j.fertnstert.2024.07.567
case-report 2023
Toxics ·doi:10.3390/toxics11121009

Potentially toxic elements (PTEs), found as environmental contaminants, have been related to endometriosis disease. In this context, the peritoneal fluid (PF) matrix has been poorly studied despite its importance. PF is the environment in w…

rct 2021
BMC women's health ·doi:10.1186/s12905-021-01347-9

BACKGROUND: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated with levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. METHODS: Prospective, randomized clinical tri…

other 2021
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.14679

AIM: To evaluate if the long-term results (on fertility, need of hysterectomy and persistence of endometriosis) after a minimally invasive intervention (transvaginal ultrasound-guided puncture-aspiration [TUGPA]) for endometriomas are signi…

preprint 2020
·doi:10.21203/rs.3.rs-51837/v1
preprint 2020
·doi:10.21203/rs.3.rs-51837/v4
preprint 2020
·doi:10.21203/rs.3.rs-51837/v2

Abstract Background: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated to levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods: Prospective, randomized clinic…

preprint 2020
·doi:10.21203/rs.3.rs-51837/v3

Abstract Background: To study the effectiveness of an aromatase inhibitor (Anastrozole) associated to levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods: Prospective, randomized clinic…

preprint 2019
·doi:10.20944/preprints201911.0010.v1

Background: Effectiveness of Anastrozole and levonorgestrel-releasing intrauterine device (LNG-IUD, Mirena®) in the treatment of endometriosis. Methods: Randomized clinical trial. Elegibility criteria: Endometriomas >3×4 cm, CA…

article 2019
Reproductive biology ·doi:10.1016/j.repbio.2019.12.001
article 2016

Copyright © 2013 P. Acién and I. Velasco. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work i…

article 2016

International Journal of Women’s Health Is a bowel resection necessary for deep endometriosis with rectovaginal or colorectal involvement?

article 2015
Gynecologic and obstetric investigation ·doi:10.1159/000367597

AIMS: To determine the prevalence of endometriosis in epithelial ovarian cancers (EOC) and the association among their histological subtypes and with endometrial carcinoma. METHODS: An observational cohort study performed in 192 patients op…

article 2013
ISRN obstetrics and gynecology ·doi:10.1155/2013/242149

Endometriosis, a gynecologic pathology, is defined by the presence of a tissue similar to uterine endometrium, which is located in places other than physiologically appropriate. These endometrial heterotopic islets contain glands and stroma…

article 2013
International journal of women's health ·doi:10.2147/ijwh.s46519

BACKGROUND: The purpose of this paper is to report the long-term results of surgery without bowel resection in patients suffering from deep infiltrating endometriosis with rectovaginal or colorectal involvement. METHODS: This retrospective …

article 2010
Journal of reproductive immunology ·doi:10.1016/j.jri.2009.11.004
article 2009
Gynecologic and obstetric investigation ·doi:10.1159/000270901

BACKGROUND: To analyze the therapeutic results of recombinant interleukin-2 (rIL-2) left in the cysts after transvaginal ultrasound (US)-guided drainage of endometriomas as an alternative to surgery. METHODS: Prospective and randomized clin…

article 2007
Fertility and sterility ·doi:10.1016/j.fertnstert.2006.11.188
article 2007

La presente tesis doctoral, estructurada en capitulos, es una investigacion original que tiene como objetivo fundamental profundizar en la inmunologia de la endometriosis e intentar apuntar hacia nuevas acciones terapeuticas para hacer fren…

other 2007
Journal of reproductive immunology ·doi:10.1016/j.jri.2006.12.001

The aim of this double-blinded study was to determine changes in leukocyte populations in blood, peritoneal lavage fluid, eutopic and ectopic endometrium after treatment with recombinant rat interleukin-2 (IL-2) using an in vivo experimenta…

article 2007
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2006.11.021
article 2006
Molecular human reproduction ·doi:10.1093/molehr/gal041

Cytochrome P-450 aromatase is responsible for catalysing the conversion of androstendione into estrone, so its expression in endometriotic tissue could contribute to the development of endometriosis. The aims of this study were, on the one …

article 2005
Fertility and sterility ·doi:10.1016/j.fertnstert.2004.10.035
article 2005
Gynecologic and obstetric investigation ·doi:10.1159/000089100

BACKGROUND: To analyze the therapeutic results of one dose of 3 million IU of recombinant interleukin-2 (rIL-2) left intracyst (group I) versus two doses with a 1-month interval (group II) after transvaginal ultrasound (US)-guided drainage …